The Prevalence and Clinical Manifestations of Human Metapneumovirus Among Children With Bronchiolitis.

This study has been completed.
Sponsor:
Information provided by:
HaEmek Medical Center, Israel
ClinicalTrials.gov Identifier:
NCT00265187
First received: December 13, 2005
Last updated: January 2, 2013
Last verified: August 2006

December 13, 2005
January 2, 2013
December 2005
March 2006   (final data collection date for primary outcome measure)
Not Provided
Not Provided
Complete list of historical versions of study NCT00265187 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
The Prevalence and Clinical Manifestations of Human Metapneumovirus Among Children With Bronchiolitis.
The Prevalence and Clinical Manifestations of Human Metapneumovirus Among Children With Bronchiolitis in Northern Israel.

Sputum specimens will be obtained from children < 2 years of age and processed by different mode for the HMPV, RSV, Pertussis, Influenza A, B, Parainfluenza 1,2,3, Adenovirus. Clinical and epidemiological data will also be obtained.

The purpose of the study is to asses the various pathogens of bronchiolitis in children and its' clinical manifestations. Prospective study in 3 Medical centers in Northern Israel. Included will be about 200 infants and children < 2 years hospitalized with bronchiolitis. From each child sputum specimen will be obtained and processed for HUMP - PCR, Pertussis - PCR, RSV - ELISA, DFA, PCR, Influenza A, B, Parainfluenza 1,2,3 - DFA, PCR, Adenovirus - DFA. Epidemiological data will be obtained for every child by structured questioner. Clinical data will be daily obtained by scoring system.

Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample

Children 0-24 months hospitalized with acute bronchiolitis

  • Respiratory Tract Infection
  • Children
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
200
March 2006
March 2006   (final data collection date for primary outcome measure)

Inclusion Criteria:Age 0-24 months, hospitalized children, -

Exclusion Criteria:Previous hospitalization, previous RSV immunization, immunocompromised patient, previous inclusion in this study, inclusion in another study.

-

Both
up to 2 Years
Yes
Contact information is only displayed when the study is recruiting subjects
Israel
 
NCT00265187
3350105
No
Dan Miron, MD, HaEmek Medical Center, Afula, Israel
HaEmek Medical Center, Israel
Not Provided
Principal Investigator: Dan Miron, MD HaEmek Medicak Center, Afula, Israel
HaEmek Medical Center, Israel
August 2006

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP